Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Novartis Pharma

This page shows the latest Novartis Pharma news and features for those working in and with pharma, biotech and healthcare.

Novartis forms coronavirus alliance with life sciences companies

Novartis forms coronavirus alliance with life sciences companies

Partnership will accelerate research with aid of Gates Foundation. Swiss pharma Novartis and a consortium of life sciences companies have partnered to accelerate the research and development of potential vaccines, diagnostics ... Last week, Novartis

Latest news

More from news
Approximately 6 fully matching, plus 535 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    It’s too early to say what style Hahn will bring to the role and its impact on the pharma sector. ... drugmaker Sanofi on 1 September last year from a prior role as head of pharma at Novartis.

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    1 trial of its lead candidate ARV-110 in prostate cancer earlier this year, ahead of rival biotechs such as C4 Therapeutics and Kymera Therapeutics as well as big pharma firms ... That’s not dampening enthusiasm for the emerging field, however, and by

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020. ... BMS will become the fourth largest pharma firm by sales – behind Pfizer, Novartis and Roche – and the addition of new Celgene brands like

  • Leo has its eyes on the prize Leo has its eyes on the prize

    We are in an era of great change and treatment advances,” says Gitte Aabo, CEO and President of Leo Pharma. ... It makes it very attractive not only for Leo but for big pharma companies such as Novartis and Celgene that are very active in this area.

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    they do badly,” added Mr Moran, who joined Novartis from McKinsey &Company as a strategic assistant to the CEO in January 2015. ... A one-off treatment, it comes with the hefty $475, 000 price tag - and a red rag to anti-pharma factions - but put

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • New hires at Bristol-Myers Squibb, Acceleron and FerGene New hires at Bristol-Myers Squibb, Acceleron and FerGene

    Acceleron . Acceleron Pharma has poached Jay Backstrom (pictured right) from Celgene, where he worked as chief medical officer. ... He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his

  • New faces at Healthware Group and HRW New faces at Healthware Group and HRW

    She spent time at Novartis representing the interests of pharma, and also worked at start-up brand Headspace.

  • Novartis changes executive committee Novartis changes executive committee

    Welteverden, who was previously head of business services for Syngenta, will join Novartis’ Basel base in Switzerland. ... Klinger initially joined Novartis back in 2011 as general counsel, North America for its biopharmaceutical arm Sandoz.

  • Pfizer’s Elizabeth Barrett joins Novartis as its oncology head Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

    She succeeds Bruno Strigini who retires. Novartis has appointed Elizabeth Barrett to head up its oncology franchise based at the group’s headquarters in Switzerland. ... Her long-time commercial pharma industry experience, marketing skills and

  • Novartis Oncology head Bruno Strigini to retire Novartis Oncology head Bruno Strigini to retire

    The head of Novartis Oncology Bruno Strigini is set to step down and retire from the pharmaceutical industry. ... Novartis CEO Joseph Jimenez said: "I'd like to thank Bruno Strigini for his contributions and achievements.

More from appointments
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest from PMHub

  • EPG Health EPG Health

    With an actionable reach of over a million HCPs globally, EPG Health provides customers (including most of the top 20 pharma companies) with an integrated toolset to:. ... Novartis, Orphan Europe, Philips, Pfizer, Roche, Sanofi, Takeda, UCB, Uriach,

  • How do you define a biotech company?

    Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... This approach is particularly apparent in some of the recent examples of technology pioneered by biotech

  • Marketing strategy in complex environments

    Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines. ... The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment.

  • Frontera Group Frontera Group

    Dreamskin Health . Eusa Pharma. Galderma . Gedeon Richter. Genzyme. Grunenthal . Leukaemia UK. ... Novartis Pharmaceuticals. Novex Pharma. Pfizer. Shire Pharmaceuticals. UCB . Vertex Pharmaceuticals.

  • Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting

    Gareth has over 20 years’ experience in senior roles in a number of pharma companies, most recently at Novartis, where he spent seven years in various roles, including Brand Lead Opthalmology, ... biggest pharma companies.” Gareth will be based at

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Quick links

Infographics

Multimedia